{
    "Trade/Device Name(s)": [
        "cobas c 111 Analyzer",
        "cobas c 111 analyzer and applied reagents"
    ],
    "Submitter Information": "Roche Diagnostics Operations",
    "510(k) Number": "K071211",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063744"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIT",
        "CFR",
        "DCN",
        "CEM",
        "CGZ",
        "JGS",
        "JJE"
    ],
    "Summary Letter Date": "April 30, 2007",
    "Summary Letter Received Date": "May 1, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.2160",
        "21 CFR 862.1100"
    ],
    "Regulation Name(s)": [
        "Discrete photometric chemistry analyzer for clinical use",
        "Aspartate amino transferase (AST/SGO) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Aspartate aminotransferase (AST)",
        "C-reactive protein (CRP)",
        "Glucose",
        "Chloride",
        "Potassium",
        "Sodium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "cobas c 111 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric",
        "Turbidimetric",
        "Ion-selective electrode (ISE)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for cobas c 111 analyzer and applied reagents for clinical chemistry, protein and electrolyte testing in professional and point-of-care settings.",
    "Indications for Use Summary": "In vitro diagnostic analyzer and reagents for quantitative determination of AST, CRP, glucose, chloride, potassium, and sodium in serum, plasma, and urine for diagnosis and treatment of liver, heart, metabolic, and electrolyte disorders.",
    "fda_folder": "Clinical Chemistry"
}